Insider · CIK 0001505148
Neil Lerner
Files at CMPX (Compass Therapeutics, Inc.). First filing Apr 8, 2025, latest Oct 2, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CMPX: Compass Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 41Moderate | CMPXbuy Compass Therapeutics, Inc. | $18k 20,000 shares | +5% | 0% from low-87% from high | |
| 28Weak | CMPXbuy Compass Therapeutics, Inc. | $2,850 2,500 shares | +1% | 0% from low-83% from high | |
| 39Weak | Compass Therapeutics, Inc. | $28k 20,000 shares | +7% | +16% from low-60% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | CMPX Compass Therapeutics, Inc. | POpen-market purchase Common Stock | +20,000 | $0.92 | $18k | 420,000 | 10 d ago |
| Sep 24, 2026 | CMPX Compass Therapeutics, Inc. | POpen-market purchase Common Stock | +2,500 | $1.14 | $2,850 | 400,000 | 17 d ago |
| Apr 7, 2025 | CMPX Compass Therapeutics, Inc. | POpen-market purchase Common Stock | +20,000 | $1.42 | $28k | 320,000 | Apr 8, 2025 |
| Feb 11, 2025 | CMPX Compass Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +200,000 | $0.00 | $0 | 200,000 | Feb 13, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.